Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Graphen Inc. is active in the Biotechnology & Pharmaceuticals technology area. The company has 2 pending office actions currently in progress. These actions are distributed across 2 distinct examiners and 2 distinct art units, showing a diverse examination process for their biotechnology applications. This spread suggests that the company's innovations are being evaluated under different technical classifications within the Biotechnology & Pharmaceuticals field.
LUO, JAMMY NMN is the busiest examiner for the portfolio, with 1 pending office action. With 2 pending office actions in total, LUO, JAMMY NMN is responsible for 1 of the company's active prosecution matters. The use of 2 distinct art units indicates that the company's innovations are being reviewed by different specialized groups, which may require distinct legal arguments for each case. This diversity in the prosecution landscape reduces the impact of any single examiner's preferences on the overall portfolio.
For a patent practitioner, the distribution of 2 pending office actions across 2 distinct examiners means that there is no single point of failure for the portfolio. Each application must be managed according to the specific requirements of its assigned examiner and art unit. This variety in the examination process provides a broader base for the company's intellectual property development across the 2 distinct art units involved in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LUO, JAMMY NMN | 1 | — | — |
| SIMS, JASON M | 1 | 44.6% | +21.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18457206 | METHOD AND SYSTEM FOR EVALUATING RISK OF SUBJECT GETTING SPECIFIC DISEASE | LUO, JAMMY NMN | — |
| 17865140 | METHOD AND COMPUTING SYSTEM FOR ESTIMATING BINDING FREE ENERGY OF MUTANT PROTEIN COMPLEX | SIMS, JASON M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17865140 | METHOD AND COMPUTING SYSTEM FOR ESTIMATING BINDING FREE ENERGY OF MUTANT PROTEIN COMPLEX | SIMS, JASON M | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18457206 | METHOD AND SYSTEM FOR EVALUATING RISK OF SUBJECT GETTING SPECIFIC DISEASE | LUO, JAMMY NMN | 1686 | §101§103 | Non-Final OA | — | Pending | Aug 28, 2023 |
| 17865140 | METHOD AND COMPUTING SYSTEM FOR ESTIMATING BINDING FREE ENERGY OF MUTANT PROTEIN COMPLEX | SIMS, JASON M | 3791 | §101§112 | Final Rejection | — | Pending | Jul 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGraphen Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jammy Nmn Luo has the most, with 1 of Graphen Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
